This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Structural Determinants of Health Impacting Latino Cancer Health Disparities: Genetic Cancer Risk Assessment
Dr. Alejandra Hurtado de Mendoza is an Assistant Professor at the Cancer Prevention and Control Program at Georgetown Lombardi Comprehensive Cancer Center. Disparities across the continuum Dr. Hurtado de Mendoza’s presentation focused on disparities in genetic cancer risk assessment, multi-level barriers that Latinos face across the genetic cancer risk assessment continuum, and an example of a multilevel intervention to decrease disparities. The presentation began by discussing how disparities in the genetic cancer risk assessment continuum begin with awareness. Only ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Latino Cancer Survivors’ Quality of Life and Survivorship Care
Dr. Kristi D. Graves is a tenured Professor of Oncology, Cancer Prevention and Control Program leader at the Lombardi Comprehensive Cancer Center, and Associate Dean for Faculty Development at Georgetown University Medical Center. Latino cancer survivorship Dr. Graves’s presentation began by discussing cancer survivorship across the cancer continuum. The National Cancer Institute’s (NCI) Office of Cancer Survivorship states that “an individual is considered a cancer survivor from the time of diagnosis through the balance of life. There are many types of survivors, including those living with cancer and those ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Adapting NCI’s Clinical Trials System to a Changed Clinical Research Environment
Dr. James H. Doroshow is Deputy Director for Clinical and Translational Research at the National Cancer Institute (NCI). This plenary session occurred at 8:30 am., Thursday, Feb. 22, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. COVID’s impact on cancer clinical trials Dr. Doroshow’s presentation began by discussing the initial and continuing effects of the pandemic environment on cancer clinical trials. From the start of the pandemic, several aspects of clinical trials were altered, including informed consent and in-person study activities. One major ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Advances in Evidence-based Digital Solutions for Supporting Latino Cancer Patients
Dr. John Piette is Professor in the School of Public Health, and Director of the Center for Managing Chronic Disease (CMCD) at the University of Michigan. Cognitive behavioral therapy Dr. Piette’s presentation began by discussing how cognitive behavioral therapy (CBT) can be used for Latino cancer patients. CBT is the most common evidence-based intervention for cancer patients struggling with mental health, symptoms, stress, and sleep. In cancer patients, CBT has been shown to help manage distress and pain, alleviate insomnia, manage fear of cancer recurrence, and reduce emotional distress and ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
The NCI Community Oncology Research Program: Opportunities to Increase Latino Participation in Clinical Trials
Dr. Brenda Adjei is Associate Director of the Office of Healthcare Delivery and Equity Research at the National Cancer Institute (NCI) Center for Cancer Research. The NCI Community Oncology Research Program Dr. Adjei’s presentation began with a discussion of Latino participation in cancer clinical trials. Diversity in clinical trials is critically important because it generates biomedical knowledge relevant to all, builds trust and trustworthiness, and contributes to reductions in health disparities and equitable research participation. Current underrepresentation in ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Conclusion
To eliminate cancer disparities in Latinx populations, Advancing the Science of Cancer in Latinos brought together researchers, scientists, physicians, healthcare professionals, patient advocates, and students from across the US and Latin America. These presenters shared research advancements, identified gaps, developed actionable goals, updated clinical best practices, described effective community interventions, and detailed professional training programs aimed at addressing inequity. In the process, most of the speakers made recommendations, either specific to their field of study or more broadly. The following are some key recommendations abstracted from their conference ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Healthcare Inequity in the Latinx Community
The Latinx population both within and outside the US has significant heterogeneity. [Velazquez-Villarreal] After all, Latin America has been a melting pot of mixed populations for 500 years, with over 20 heritage groups recognized by the Hispanic Community Health Study/Study of Latinos. These groups are distinct, with unique culture, language, and US influence, but are also connected by more similarities than differences. [Perez-Stable] Latinx individuals are the largest and youngest minority in the US and are projected to account for more than half of the overall growth through 2060. Compared to non-Hispanic White individuals, Latinx ...
While engaging in the recommended amount of physical activity is a key part to lowering your risk factors for certain diseases like heart disease and diabetes, it doesn’t necessarily mean your risk has diminished. A new study published in PLOS One found that even though you exercise, sitting for long periods of time can be detrimental to your health. The study examined the correlation between activity intensity and sitting. Let’s dig into the results of the study and discover ways to combat physical inactivity for a healthier you!
Study Findings on Sitting and Physical Activity
The study, led by researchers at the University of California, Riverside, examined data from adults aged 28 to 49, many of whom spend an average of 9 hours a day sitting. ...
Dr. Amelie G. Ramirez, leader of Salud America! at UT Health San Antonio, appeared alongside other breast cancer experts and oncologists at the 2024 San Antonio Breast Cancer Symposium. The San Antonio Breast Cancer Symposium is an annual conference that delivers important on breast cancer research, therapy, biology, diagnosis, and prevention for an international audience of thousands of virtual and in-person attendees. During the symposium, physicians and researchers learn by attending lectures given by experts in clinical, translational, and basic research, discussions, forums, and presentations, including poster presentations. While in attendance Ramirez brought awareness to the need for more cancer prevention and getting information out to underserved populations ...
